GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cadence Pharmaceuticals, Inc. (CADX) [hlAlert]

Rating:
Buy CADX
up 96.34 %

Cadence Pharmaceuticals, Inc. (CADX) upgraded to Buy with price target $8.60 by Ladenburg Thalmann

Posted on: Wednesday,  May 15, 2013  9:25 AM ET by Ladenburg Thalmann

Ladenburg Thalmann rated Buy Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) on 05/15/2013, when the stock price was $7.12. Since
then, Cadence Pharmaceuticals, Inc. has gained 96.35% as of 03/18/2014's recent price of $13.98.
If you would have followed this Ladenburg Thalmann's recommendation on CADX, you would have gained 96.34% of your investment in 307 days.

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing its product candidates principally for use in the hospital setting. The Company has in-licensed rights to two late stage product candidates, Acetavance a intravenous formulation of acetaminophen and Omigard (omiganan pentahydrochloride) 1% aqueous gel. It has in-licensed the exclusive United States and Canadian rights to Acetavance, that is marketed in Europe for the treatment of acute pain and fever by Bristol-Myers Squibb Company (BMS). The Company has also in-licensed the rights to commercialize Omigard in North American and Europe.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/15/2013 9:25 AM Buy
None
7.12 8.60
as of 12/13/2013
1 Week down  -5.87 %
1 Month up  59.60 %
3 Months up  56.54 %
1 YTD up  25.98 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/7/2011 2:25 PM Hold
None
8.49 8.00
11/3/2010 8:25 AM Sell
None
7.92 6.00
8/6/2009 8:25 AM Hold
None
11.55 12.00
7/16/2009 9:25 AM Hold
None
11.00 11.00
4/6/2009 9:25 AM Hold
None
9.52 10.00
11/24/2008 10:25 AM Buy
None
6.00 10.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy